Vivos Therapeutics (VVOS) Expected to Announce Earnings on Thursday

Vivos Therapeutics (NASDAQ:VVOS) is anticipated to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.43) per share and revenue of $3.89 million for the quarter.

Vivos Therapeutics Trading Up 3.1 %

VVOS stock opened at $3.71 on Tuesday. Vivos Therapeutics has a 1-year low of $1.91 and a 1-year high of $6.28. The business’s 50-day moving average price is $3.96 and its two-hundred day moving average price is $3.60. The firm has a market cap of $21.85 million, a PE ratio of -0.65 and a beta of 7.47.

Vivos Therapeutics Company Profile

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.